ArticlePhysiology (Bethesda, Md.)2022

Therapeutic Targeting of Hypoxia-A2-Adenosinergic Pathway in COVID-19 Patients.

Katarina Halpin-Veszeleiova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.